AMSTERDAM--(BUSINESS WIRE)--Annogen, the Amsterdam based biotech company behind the SuREâ„¢ technology for the functional annotation of the non-coding part of the genome, today announced it has begun a ...
Nearly 25 years after scientists completed a draft human genome sequence, many of its 3.1 billion letters remain a puzzle. The 98% of the genome that is not made of protein-coding genes — but which ...
Profiling noncoding repetitive RNA sequences improves the sensitivity of liquid biopsy diagnostic tests for early stage cancers. As cancer is most treatable in its early stages, developing diagnostic ...